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Abstract
Background: The present study was designed to test the hypothesis that chronic very mild
prenatal carbon monoxide (CO) exposure (25 parts per million) subverts the normal development
of the rat cerebellar cortex. Studies at this chronic low CO exposure over the earliest periods of
mammalian development have not been performed to date. Pregnant rats were exposed
chronically to CO from gestational day E5 to E20. In the postnatal period, rat pups were grouped
as follows: Group A: prenatal exposure to CO only; group B: prenatal exposure to CO then
exposed to CO from postnatal day 5 (P5) to P20; group C: postnatal exposure only, from P5 to
P20, and group D, controls (air without CO). At P20, immunocytochemical analyses of oxidative
stress markers, and structural and functional proteins were assessed in the cerebellar cortex of the
four groups. Quantitative real time PCR assays were performed for inducible (iNOS), neuronal
(nNOS), and endothelial (eNOS) nitric oxide synthases.
Results: Superoxide dismutase-1 (SOD1), SOD2, and hemeoxygenase-1 (HO-1) immunoreactivity
increased in cells of the cerebellar cortex of CO-exposed pups. INOS and nitrotyrosine
immunoreactivity also increased in blood vessels and Purkinje cells (PCs) of pups from group-A, B
and C. By contrast, nNOS immunoreactivity decreased in PCs from group-B. Endothelial NOS
immunoreactivity showed no changes in any CO-exposed group. The mRNA levels for iNOS were
significantly up-regulated in the cerebellum of rats from group B; however, mRNA levels for nNOS
and eNOS remained relatively unchanged in groups A, B and C. Ferritin-H immunoreactivity
increased in group-B. Immunocytochemistry for neurofilaments (structural protein), synapsin-1
(functional protein), and glutamic acid decarboxylase (the enzyme responsible for the synthesis of
the inhibitory neurotransmitter GABA), were decreased in groups A and B. Immunoreactivity for
two calcium binding proteins, parvalbumin and calbindin, remained unchanged. The
immunoreactivity of the astrocytic marker GFAP increased after prenatal exposure.
Conclusion: We conclude that exogenously supplied CO during the prenatal period promotes
oxidative stress as indicated by the up-regulation of SOD-1, SOD-2, HO-1, Ferritin-H, and iNOS
with increased nitrotyrosine in the rat cerebella suggesting that deleterious and protective
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mechanisms were activated. These changes correlate with reductions of proteins important to
cerebellar function: pre-synaptic terminals proteins (synapsin-1), proteins for the maintenance of
neuronal size, shape and axonal quality (neurofilaments) and protein involved in GABAergic
neurotransmission (GAD). Increased GFAP immunoreactivity after prenatal CO-exposure
suggests a glial mediated response to the constant presence of CO. There were differential
responses to prenatal vs. postnatal CO exposure: Prenatal exposure seems to be more damaging;
a feature exemplified by the persistence of markers indicating oxidative stress in pups at P20,
following prenatal only CO-exposure. The continuation of this cellular environment up to day 20
after CO exposure suggests the condition is chronic. Postnatal exposure without prenatal
exposure shows the least impact, whereas prenatal followed by postnatal exposure exhibits the
most pronounced outcome among the groups.
Background
Carbon monoxide (CO) is a colorless, tasteless and odor-
less gas product of the incomplete combustion of carbon-
based fuels and other carbonaceous substances [1]. From
a public health perspective, CO toxicity is the most com-
mon type of accidental poisoning in the United States and
the cause of more that 50% of fatal poisonings in many
industrial countries [2,3]. CO has been also identified as
an important endogenous biological messenger in the
brain [4,5], and it is a major component in the regulation
of the cerebro-vascular circulation in newborns [6]. The
central nervous system (CNS) is the most sensitive tissue
to CO, and usually suffers the greatest lasting damage
from CO poisoning [7].
There is an increase in clinical awareness that a link exists
between chronic exposure to CO and the etiology of vas-
cular or cardiovascular diseases [1,8-10]. Several studies
on humans (prenatal and postnatal periods) provide data
that CO and cigarette smoke affects normal growth and
development [11-14]. Adverse effects of prenatal tobacco
smoke exposure on the developing brain stem in humans
have also been reported [15]. CO readily crosses the pla-
centa and binds to fetal hemoglobin [12,16]. Gestational
exposure to CO impairs vascular reactivity in rat offspring
at different stages of neurogenesis [17]. The developing
CNS and peripheral nervous system are extremely suscep-
tible to the reduction of oxygen availability produced by
CO exposure [18], and both neurobehavioral and neuro-
chemical alterations have been found in male rat off-
spring exposed to low levels of CO during gestation
[17,19-21]. Adverse effects have been found in the devel-
oping peripheral tissues of a prenatal exposure model that
simulates the CO exposure conditions observed in human
cigarette smokers [13].
As reviewed by Benagiano et al., [22,23], numerous
reports suggest that intrauterine and neonatal exposure to
mild CO concentrations affects the course of CNS devel-
opment. Studies have been done with chronic exposure of
pregnant rats to CO at 75–150 ppm; concentrations
below those associated with gross malformations or overt
neurotoxic effects in the offspring [22,23]. However, mild
CO exposure induced long-lasting consequences in the
prenatal developing nervous system, and it is possibly
implicated in the pathogenesis of persistent permanent
neurological disorders detectable in adulthood [24-27].
Various biochemical and functional alterations have been
found postnatally in the rat CNS after such relatively mild
prenatal exposure to CO, including: change in the content
of some neurotransmitters in the brain stem and cerebel-
lum [28-30], dysfunction of the dopaminergic mesolim-
bic system [19], impairment of the maintenance of long
term potentiation associated with a decreased activity of
the enzymes heme oxygenase-2 (HO-2) and nitric oxide
synthase (NOS) in the hippocampus [12].
The cerebellum is a highly organized structure in which
Purkinje cells (PCs) are the sole output of the cerebellar
cortex [31-34], and it is one of the first structures of the
brain to differentiate, however, it achieves its mature con-
figuration many months after birth [35,36]. For this rea-
son the cerebellum is especially vulnerable to
developmental irregularities [36,37]. Exposure to CO
induces the formation of COHb and consequently a
decrease of the tissue oxygen supply (hypoxia) [22,23].
The developing cerebellum is highly susceptible to prena-
tal CO exposure at low concentrations [28,29]. Studies on
animal models have shown that PCs are vulnerable to
ischemia, hypoxia, excitotoxicity, oxidative stress and
exposure to different types of chemicals [37]. It has been
well documented that prenatal CO exposure has selective
effects on the different cell types [22]. Benagiano et al.,
found that Purkinje and Golgi neurons did not appear to
be susceptible, unlike the postnatally generated stellate
and basket neurons [22]. For these reasons it is possible
that very mild chronic exposure to CO may affect cerebel-
lar neurons.
We have previously studied the effect of chronic mild CO
exposures in the concentration range 12–25 ppm (con-
centrations at or below upper limits established by severalBMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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regulatory agencies) in the developing auditory system of
the rat [38-42]. The present study was designed to test the
hypothesis that chronic very mild prenatal CO exposure
(25 ppm) subverts the normal development of the cere-
bellar cortex. Pregnant rats at E5 were exposed to CO at 25
parts per million (ppm). Rat cerebella were examined by
immunocytochemical methods at postnatal day 20 (P20).
Specifically we examined the immunolocalization of oxi-
dative stress proteins as well as proteins relevant to cere-
bellar function and development. Oxidative stress
markers included superoxide dismutase-1 (SOD-1) and
SOD-2, heme-oxygenase-1 (HO-1), and HO-2, inducible
nitric oxide synthase (iNOS), neuronal NOS (nNOS) and
endothelial NOS (eNOS) and Ferritin. The presence of
nitrotyrosine (NT) was also investigated. Neurons were
identified using pan-neurofilaments, and the presence of
synaptic terminals was studied using antibodies against
synapsin-1. Glial cells were identified using glial fibrillary
acidic protein (GFAP). Two calcium binding proteins, par-
valbumin (PV) and calbindin-D28K (CB) were also used
to identify neurons of the cerebella and their terminals. To
determine whether the GABAergic system of the cerebella
was altered after CO exposure, we used antibodies against
glutamic acid decarboxylase (GAD-67). Preliminary por-
tions of these data have been presented in abstract form
[43,44].
Methods
Animal use
The Chancellor's Animal Subject Protection Committee at
the University of California, Los Angeles, approved the
research protocol for the use of animal subjects in this
study. Animals were handled and cared for in accordance
with the Animal Welfare Act and in strict compliance with
the National Institutes of Health Guidelines.
CO exposure
Pregnant Sprague-Dawley rats (second or third litter expe-
rience) were obtained from the supplier (Charles River) at
2 days of gestation. Cages containing the pregnant rats
were enclosed by gas tight chambers that were constructed
of clear plastic to contain 130 liters of air and through
which gas flowed at controlled rates to obtain the desired
CO exposure conditions. The chambers were removed
from the exposure system daily to allow for the mainte-
nance of the animals [40,43]. The gas delivered to the CO-
chamber contains a combination of 25 ppm CO in 22%
oxygen with the balance of the gas as nitrogen and carbon
dioxide at appropriate levels. Gas was administered con-
tinuously for 10–18 hours during the day and the gas sup-
ply-system and chambers removed at night
(approximately 10 hrs). Oxygen concentrations have been
shown to never fall below 21.5% in the air breathed by the
animals. The same gas mixture but without CO was deliv-
ered to the chambers containing the control animals [42].
Animal groups
Group A consists of rat pups born from pregnant rats
exposed to CO (25 ppm) from E5 to E20. Group B, consist
of rat pups exposed as group A and then exposed again to
CO from P5 to P20. Group C consists of rat pups from
mothers not exposed prenatal to CO (air without CO
only), but exposed to CO in the postnatal period from P5
to P20. Group D are the controls that were never exposed
to CO at any time. For the rats to be exposed to CO in air,
or air without CO, postnatal day 0 (P0) is the calendar day
on which the rat pups were born. There was no difference
in the body weight of rat pups (from comparable litter
sizes) between CO exposed and air-only exposed rat pups.
This experiment was repeated three times.
Tissue processing
On P20, CO exposed rat pups and age-matched controls
were over anesthetized with halothane, and then decapi-
tated. The whole brain was dissected from the head, and
then immersed in 4% sodium phosphate buffered (0.11
M, pH 7.4) paraformaldehyde solution for 8–12 hours.
Thereafter the whole brain was immersed in 30% sucrose
dissolved in buffered phosphate saline solution (PBS), for
5–7 days. The cerebella was separated from the brain and
embedded with O.C.T. compound (Tissue-Tek, Ted
Pella), and 20 μm thick sagittal sections were obtained
(Cryostat, model Microm HN505E). Tissue sections were
mounted on Superfrost Plus glass slides (Fisher Scientific)
and stored at -80°C until their use.
Immunocytochemistry
Cerebella from each group were dehydrated, embedded in
Paraffin Paraplast (Fisher Scientific), and 20 μm thick sec-
tions were obtained. Before immunocytochemistry paraf-
fin was removed and tissue sections were rehydrated.
Sections were incubated at room temperature for 10 min-
utes with 3% hydrogen peroxide (diluted in 100% meth-
anol), then washed three times with PBS and incubated
one hour with a blocking solution containing 5% normal
goat or horse serum and 1% Triton X-100 diluted in buff-
ered PBS. Next, the solution was removed and the primary
polyclonal or monoclonal antibody was applied to the tis-
sue sections at dilutions indicated in Table 1. Tissue sec-
tions were incubated in a humid chamber at 4°C for 48
hrs. Tissue sections were then incubated with the bioti-
nylated goat anti-rabbit or goat anti-mouse secondary
antibody (1:250) for 1 hour at room temperature (Elite
kit, Vector Labs). Sections were then incubated with the
avidin-biotin-peroxidase solution ABC (Elite kit, Vector
Labs) for 1 hour at room temperature. The antigen-anti-
body reaction was visualized using diaminobenzidine
(DAB) as the chromogen (Vector labs Kit). The reaction
was halted after 2–4 minutes with distilled water (15 min-
utes × 3). The sections were coversliped with Vector aque-BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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ous mounting media for light microscopic examination
(Vector Labs).
For immunofluorescence, cryostat prepared sections from
the rat cerebella were incubated at room temperature for
1 hour with a blocking solution containing 1% bovine
serum albumin (Fraction V, Sigma, SLM) and 1% Triton
X-100 (Sigma) diluted in PBS. Next, the solution was
removed and the primary polyclonal or monoclonal anti-
body was applied to the tissue sections. Antibodies and
dilutions used are listed in Table 1. Tissue sections were
incubated in a humid chamber at 4°C for 48 hrs. At the
end of the incubation, tissue sections were washed 3 times
for 10 minutes each in PBS. The secondary antibodies
against rabbit or mouse primary antibodies and labelled
with Alexa 488 or 594 (diluted 1:1000 in PBS, Molecular
Probes) were applied and incubated for 1 hour at room
temperature in the dark. At the end of the incubation, tis-
sue sections were washed with PBS (3 × 10 min), and
mounted with Vectashield solution (Vector Labs).
Table 1: Antibodies used in the present study, source, dilution, type, species reactivity, immunogen, negative and positive controls 
used.
Antibody/Source Dilution/antibody type Species reactivity/
immunogen ***
Negative control Positive control/cellular 
location
Pan neurofilament/Zymed 1:500/mouse monoclonal Rat, mouse, human/human 
cocktail neurofilament low, 
middle and high molecular 
weight peptides
No antibody on ICC Mouse, rat human, 
cerebellar cortex*/neuron 
perikarya and axons
Synapsin-1/Chemicon 1:1000/rabbit polyclonal Rat, bovine, human/synapsin I 
(Ia and Ib) bovine brain
No antibody on ICC Mouse, rat cerebellar 
cortex*/nerve terminals
Calbindin/Sigma 1:1000/mouse monoclonal Rat, mouse, human, goat/
bovine kidney – calbindin D-
28k
No antibody on ICC Mouse, rat cerebellar 
cortex*/Purkinje cell 
arborization
Parvalbumin/Chemicon 1:1000/mouse monoclonal Rat, human, bovine/
Parvalbumin purified from 
frog muscle
No antibody on ICC Purkinje cell arborization, 
basket cells mice and 
human cerebella
SOD-1/Santa Cruz 1:500/rabbit polyclonal Rat, mouse, human/aa 1–154 
full length human SOD-1
Antibody absorption with 
peptide on ICC
Rat* and mice** intestine/
luminal epithelial cells
SOD2/Abcam 1:1000/rabbit polyclonal Drosophila and several 
vertebrates/full length rat 
SOD-2 protein
No antibody on ICC Mouse and rat cerebellar 
cortex and brain stem/
neuronal soma
HO-1/Santa Cruz 1:500/Goat polyclonal Rat, mouse, human/peptide 
mapping C-terminus of HO-
1 of rat origin
Antibody absorption with 
peptide on ICC
Rat postnatal day 6 
cerebellum cortex*/
neurons and blood vessels
HO-2/ 1:1000/Rabbit Rat, mouse, human, rabbit, 
cow, dog/full length protein
No antibody on ICC Rat cerebellum*/Purkinje 
cell soma
Abcam iNOS/Chemicon polyclonal 1:1000/rabbit 
polyclonal
Rat, mouse/C-terminal 14 aa 
peptide from mouse 
macrophage iNOS
No antibody on ICC LPS mouse brain, inner 
ear*/macrophages in blood 
vessels
nNOS/Calbiochem 1:1000/rabbit polyclonal Rat, mouse, human/peptide 
corresponding amino acids 
724–739 of human brain 
NOS coupled to KHL
No antibody on ICC Normal rat, mice, PCs and 
layer 5 primary neurons
eNOS/Chemicon 1:500/mouse monoclonal Rat, mouse, bovine, human/
Bovine eNOS purified from 
cultured aortic EC
No antibody on ICC Blood vessels from human 
and mouse brain.
GFAP/Sigma 1:1000/Mouse monoclonal Rat, pig, human/Purified 
GFAP from pig spinal cord
No antibody on ICCH u m a n  c o r t e x  a n d  
cerebella.
Nitrotyrosine/Chemicon 1:1000/mouse polyclonal Rat, mouse, human/nitrated 
KLH
No antibody on ICC Normal human 
cerebellum** 95 year old/
neuronal somata
GAD67/Chemicon 1:2000/mouse monoclonal Rat, mouse, human/
Recombinant GAD67 
protein
No antibody on ICC Normal mouse brain and 
cerebellum.
Ferritin H/Santa Cruz 1:500/rabbit polyclonal Rat, mouse, human/aa 131–
183 of ferritin heavy chain of 
human
No antibody on ICC Normal human cerebellar 
cortex** 98 year old/
neuronal somata
Ferritin L/Sigma 1:1000/rabbit polyclonal Rat, mouse, human horse 
spleen ferritin
No antibody on ICC Normal human cerebellar 
cortex** 98 year old/glial 
cells
* From rats in the present study, ** Tissue available at authors laboratory, aa: amino acid, ICC: immunocytochemistry; LPS: lipo-polysaccharide 
treated mice; P: postnatal day; *** as per vendor specifications.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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Positive and negative controls are described in Table 1.
For the negative controls, sections were incubated with all
solutions except for the primary antibodies during the
immunocytochemical procedure. In the negative controls
no specific immunoreactivity was detected. Cerebellar
cortex sections from young normal mice and rats were
used as positive controls for neurofilament proteins, syn-
apsin-1 and GFAP. Lung and kidney sections from non-
CO exposed controls were examined with antibodies
against HO-1, SOD-1 and iNOS as positive controls
(Table 1).
Light and fluorescent microscopic documentation for 
quantification
The distribution of the cellular markers (Table 1) was
studied in sagittal sections of the rat cerebella, located lat-
eral 0.10 mm to 1.4 mm [45]. The cerebellar cortex is a
complex but uniform structure; however, the functions of
the different regions depend on the afferent input and the
targets of the afferent commands [31-36]. Therefore for
quantitative analysis it is important to sample the cerebel-
lar cortex in a systematic fashion. To avoid bias, quantita-
tive immunocytochemical analyses was made consistently
on micrographs obtained randomly from the cerebellar
cortex in lobules V to VIII [31-34].
Sections were viewed and imaged (at 200×) with an
Olympus BX51 fluorescent microscope (Olympus Amer-
ica Inc, NY, USA) equipped with an Olympus DP70 dig-
ital camera. To provide unbiased comparisons of the
immunoreactive signal from a particular antibody
between each specimen, all images were captured using
strictly the same camera settings. Images were acquired
using MicroSuite™ Five software (Olympus America Inc).
All images were prepared using the Adobe Photoshop™
software program run in a Dell Precision 380 computer.
This program was used to optimize brightness and con-
trast, but not to enhance or change the image content.
Photomicrographs for each cellular marker shown in this
study illustrate representative immunocytochemical
staining from representative sections from three rats cere-
bella/group from each of 3 different CO-exposure experi-
ments (n = 9).
For quantitative immunocytochemistry cerebellar cortex
sections for each experimental group were (simultane-
ously) immunoreacted with the same batch of antibodies
and buffers. Tissue sections were incubated for the same
period of time and secondary antibodies were washed at
the same time (for fluorescent stained slides) or the DAB-
HRP reaction were stopped at the same time using a chro-
nometer.
Quantification
Quantification of immunoreactivity was assessed and
measured objectively by 2 independent observers. Immu-
noreactivity (DAB-chromogen and fluorescent signal) was
measured using the ImageJ software program (Version
1.42 k, National Institutes of Health, USA, http://
rsb.info.nih.gov/ij. ImageJ is a public domain program).
Quantification methods were performed as described by
others [46-48] and adapted to our immunoreacted tissue
sections from the cerebellar cortex. As outlined above
immunoreactivity for each cellular marker was measured
consistently in three regions of each section of the cerebel-
lar cortex within lobules V and VIII. Measurements per
bio-marker were made on 3 immunostained tissue sec-
tions obtained from 3 rat cerebella per group/experiment.
The area of the entire cerebellar cortex (molecular,
Purkinje and granular) was selected with rectangular
selection tools. The chromogen, or fluorescence intensity
of the selected (fixed) area was measured with analyze
function-measurement RGB to obtaining a mean value.
Green (Alexa Fluor 484) and red (Alexa Fluor 596) meas-
urements (values) were used for quantification. Diami-
nobenzidine (chromogen) stained images were inverted
with the Edit tool and blue color values were used for
quantification. A background intensity was determined in
a small window located away from the immunoreactive
signal and was subtracted from the chromogen or fluores-
cence intensity value of the immunoreacted structures.
Statistical Analyses
Mean values of chromogen or fluorescent intensity were
averaged and subjected to one way repeated measures
ANOVA analysis. Comparisons were made between group
D and A, D and B, and D vs. C. Values were considered sta-
tistically significant at p ≤ 0.05. The Sigma Stat 3.1 soft-
ware program (Jandel Scientific, San Rafael, CA) was used
for statistical analyses.
RNA isolation for real time RT-PCR
At the end of CO or air exposure rat pups were killed (as
described above), the cerebellum was separated from the
brain, and cut in two halves (sagittal) that were immedi-
ately snap frozen in liquid nitrogen and stored at -80°C.
Some cerebellar tissue from these animals was used for
another study reported, in part, in an abstract [49].
Before RNA isolation, frozen cerebellum samples from
each group were immersed in RNAlater-ICE stabilizing
solution (Ambion Inc., Austin, TX) and retained at -20°C
for 16 hrs before RNA extraction. Each sample was then
transferred into a sterile polypropylene centrifuge tube
containing 1 ml of TRIzol solution (Invitrogen, Carlsbad,
CA). Samples were homogenized (by sonication) using a
dis-membrator (Model 100, Fisher Scientific) for 10 sec at
room temperature (RT), and incubated in the TRIzol solu-
tion for 5 minutes. Two hundred μl of chloroform were
added to the sample and thereafter shaken vigorously.
Each sample was incubated 5 minutes at RT and centri-BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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fuged at 12,000 g for 15 minutes at 4°C. Five hundred μl
of isopropanol were added to the supernatant to precipi-
tate RNA. Ten minutes later the sample was centrifuged at
12,000 g for 10 min at 4°C. The supernatant was dis-
carded and the pellet resuspended in 100 μl diethylpyro-
carbonate (DEPC)-treated water.
RNA was first treated with DNAse to eliminate any con-
taminating genomic DNA before the conversion of RNA
to cDNA. In brief, RNA was placed into a 200 μl PCR tube
to which the following solutions were added: 10 μl of 10×
RDD buffer (Qiagene), 2.5 μl of RNAse-Free DNAse I (6.8
units, Qiagene), and nuclease-free H2O to a final volume
of 100 μl. The tube was placed into a thermocycler (Model
9600, Perkin Elmer) and incubated at 25°C for 10 min.
DNAse was removed during the cleanup procedure using
the RNeasy MinElute cleanup protocol (Qiagene). The
resulting purified and concentrated RNA was quantified
by a Qubit™ fluorometer using the Quanti-T assay kit (Inv-
itrogen). Total RNA integrity and size distribution were
checked by denaturing agarose gel electrophoresis and
SYBR staining.
Retrotranscription and RT-PCR
Total RNA was reverse transcribed using oligo (dT) 12–18
primers and SUPERSCRIPT III (Superscript III RT, Invitro-
gen) in a final volume of 20 μl at 42°C for 50 minutes.
Real-time PCR was performed using 1 μL of cDNA for
each reaction (equivalent to 50 ng of total RNA), 12.5 μL
of SYBR Green/ROX qPCR, master mix from SuperArray
BioScience Corporation (Frederick, MD, USA), 10.5 μl of
ddH2O and 1 μl of the following rat gene-specific primers:
β-actin (Cat # PPR06570B), nNOS also called NOS1 (Cat
# PPR44930E), iNOS also called NOS2 (Cat #
PPR44835A), and eNOS also called NOS3 (Cat #
PPR49724A) all from SuperArray (in a final volume of 25
μL). All experiments were performed in triplicate and the
PCR reaction mixture was run in the Mx3000P Real Time
PCR-System (Stratagene). The thermal cycling conditions
included an initial denaturizing step at 95°C for 10 min,
40 cycles at 95°C for 10 s, 60°C for 20 s, and 72°C for 30
s, followed by melting curves to differentiate non-specific
primer-dimmers and specific amplicon. Each cDNA sam-
ple was tested for target genes of interest and a housekeep-
ing gene. To verify that the reagents were not
contaminated with DNA, or that the primers do not pro-
duce a signal by dimmer formation, a no-template control
sample was included for each primer set. Amplicons were
analyzed by 4% agarose gel electrophoresis.
Data analyses
The threshold cycle (CT) is defined as the PCR cycle
number at which the fluorescence intensity crosses a man-
ually determined threshold value, at a level where the flu-
orescent signal is appreciably above the background level
but is still in the early exponential phase of amplification.
Each of the 4 samples in each group was assayed in tripli-
cate, the resulting CT values were averaged and the stand-
ard deviation calculated. If the standard deviation of the
triplicate values was more than 0.3 then the value for that
sample was not used in the final analysis. Next, for each
pool of RNA the difference in the averaged CT values (CT-
avg) for a gene of interest and β-actin for a given experi-
mental group was calculated and defined as ΔCT for each
gene of interest. The ΔCT value for each of four pools for
each experimental group was then averaged and the
standard deviation (S.D.) calculated. For each gene the
average ΔCT value for the control group (group D), was
subtracted from the average ΔCT value of the experimen-
tal groups (A, B, and C) resulting in the ΔΔCT. The error
associated with ΔΔCT was equivalent to the standard devi-
ation of the mean of the ΔCT for the experimental group.
The data are reported as fold change, which was calculated
as 2-ΔΔCT. This assumes doubling of products every ampli-
fication cycle or 100% amplification efficiency. The stand-
ard error is represented as 2-(ΔΔCT ± SD). The significance of
the ΔΔCT values was evaluated by performing a Student t-
test using Sigma Stat software (Jandel Scientific, San
Rafael, CA) with a p = 0.05 considered to be statistically
significant.
Results
Superoxide dismutase-1 immunoreactivity (SOD-1-IR)
SOD-1-IR was elevated in the cytoplasm of PCs, basket
and granular cells in groups A, B and C (Fig. 1a, a1, and
1a2), especially in group B, when compared to the con-
trols in group D (Fig. 1a3) where cells of the molecular
layer showed a modest staining of SOD-1-IR. Quantita-
tively SOD-1-IR showed a significant increase in groups A,
B and C with respect to group D (p ≤ 0.05) (Table 2).
Superoxide dismutase-2 immunoreactivity (SOD-2-IR)
SOD-2-IR was elevated in PCs and basket cells in groups
A and B (Fig. 1b and 1b1), when compared to group C
and group D (Fig. 1b3) where cells of the molecular layer
showed a modest staining of SOD-2-IR. Quantitatively
SOD-2-IR showed a significant increase in groups A and B,
but not in group C, with respect to group D (p ≤ 0.05)
(Table 2).
Heme oxygenase-1 immunoreactivity (HO-1-IR)
Figs. 1c and 1c1 shows that HO-1-IR was increased in PCs,
basket and granular cells as well as the neuropile of the
cerebellar cortex in CO exposed group A and B respec-
tively. Less prominent HO-1-IR was observed in group-C
(Table 2). HO-1-IR in the controls (group D) is minimal,
(Fig. 1c3). Quantitatively HO-1-IR showed a significantBMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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increase in groups A, B and C with respect to the control
in group D (p ≤ 0.05) (Table 2).
Inducible (iNOS), neuronal (nNOS) and endothelial nitric 
oxide synthase (eNOS) immunoreactivity
There was a significant increase of iNOS-IR in the soma of
the Purkinje and basket cells of the cerebellar cortex of
groups A, B and C (Fig. 2a, a1 and 2a2 respectively) when
compared to group D (Fig 2a3). Inducible-NOS-IR was
also present in endothelial cells of the blood vessels (Fig.
2a, a1 and 2a2). Quantitatively iNOS-1-IR showed a sig-
nificant increase in groups A, B and C with respect to the
control in group D (p ≤ 0.05) (Table 2).
Neuronal-NOS-IR was reduced in PCs of group B (Fig.
2b1), with less significant changes in groups A and C (Fig
2b and 2b2, respectively), when compared with group D
(Fig. 2b3). Quantitatively nNOS-IR showed a significant
decrease in group B with respect to group D (p ≤ 0.05)
(Table 2), however, no significant changes were seen in
nNOS-IR in-group A and C.
Endothelial-NOS-IR was present in blood vessels of the
cerebellar cortex and remained unchanged in all CO-
groups (Fig. 2c, c1 and 2c2) when compared to group D
(Fig. 2c3). Quantitatively eNOS-IR showed no significant
changes in groups A, B and C with respect to group D
(Table 2).
NOS mRNA expression
Gene expression levels for iNOS, nNOS and eNOS were
determined by real time PCR using SYBG and the data
normalized according to the level of β-actin mRNA, a
non-regulated reference gene (Fig. 3). Data were expressed
SOD-1, SOD-2 and HO-1 IR in the cerebellar cortex of CO-exposed rats and their age matched controls Figure 1
SOD-1, SOD-2 and HO-1 IR in the cerebellar cortex of CO-exposed rats and their age matched controls. Fig. 
(a), (a1) and (a2), SOD-1-IR in group A, B, and C respectively (appearing as an amber colored precipitate) was present in neu-
rons of the molecular (M), Purkinje (P), and granular (G) layers (see arrows). (a3) group D shows normal SOD-1 IR. Fig. (b), 
and (b1), shows SOD-2-IR in neuronal bodies in M and P layers (see arrows). (b2) group C in contrast, showed less pro-
nounced SOD-2-IR. (b3) group D shows normal SOD-2 IR. Fig. (c), and (c1), shows elevated HO-1-IR in neuronal bodies in M, 
P, and G layers (see arrows). (c2) group C, showed less pronounced HO-1-IR. (b3) control group D shows basal HO-1-IR. 
Hematoxylin (in purple color) identifies cell nuclei. Bar in all Figs. is 150 um.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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as fold change where the data for the group D, the refer-
ence, was assigned 1 fold (no change or normative value).
Graphs in fig. 3a, b and 3c show a comparison of the three
CO-exposure groups A, B and C with the control group D.
There was a significant increase in the expression of iNOS
mRNA in the cerebella from group B. INOS mRNA expres-
sion also increases in groups A and C, however, this
increase was less significant than group B. Neuronal-NOS
and eNOS showed a less than 1 fold change in mRNA
expression in all three CO groups with respect to the con-
trol.
Nitrotyrosine immunoreactivity (NT-IR)
NT-IR was found in blood vessels of the molecular layer
in groups A, B and C (Fig. 4a, b, and 4c). PC bodies
showed NT-IR to a lesser degree. NT-IR was not detected
in controls (Fig. 4d). Quantitatively NT-IR was signifi-
cantly increased in all CO groups with respect to group D
(p ≤ 0.05) (Table 2).
Neurofilaments (NF) and glial fibrilar acidic protein 
(GFAP) immunoreactivity (IR)
Decreased NF-IR was observed in groups A, B and C. Spe-
cifically NF-IR was decreased in the cytoplasm of PCs, bas-
ket cells and granular cells (Fig. 5a, a1 and 5a2) when
compared with group D (Fig. 5a3). Quantitatively NF-IR
was significantly decreased in all CO groups with respect
to group D (p ≤ 0.05) (Table 2). GFAP-IR was increased in
glial cells of the cerebellar cortex of group A (Fig. 5b1).
GFAP-IR in-groups B and C (Fig. 5b1 and 5b2) were sim-
ilar to group D (Fig. 5b3). GFAP-IR was significantly
increased in-group A, but not in groups B and C (p ≤ 0.05)
(Table 2).
Parvalbumin (PV), GAD, calbindin (CB), and Synapsin-1 
immunoreactivity
PV-IR in all CO-exposed groups (Fig. 6a, a1 and 6a2) was
similar to the control group (Fig. 6a3). There were no sig-
nificant quantitative changes in PV-IR between groups
(Table 2). In contrast GAD-IR was reduced in the soma of
PCs, and in the cells in the molecular layer of CO exposed
rat groups A, B and C (Fig. 6b, b1 and 6b2) when com-
pared to group D (Fig. 6b3). Quantitatively GAD-IR was
significantly decreased in groups A, B and C with respect
to group D (p ≤ 0.05) (Table 2). CB-IR remains
unchanged in groups A, B and C (Fig. 6c, c1 and 6c2) with
respect to the controls (Fig. 6c3). There were no significant
quantitative changes in CB-IR among groups (Table 2).
Synapsin-1-IR was decreased significantly in nerve termi-
nals in the molecular layer in-group A and B (Fig. 6c and
6c1) and almost unchanged in-group C (Fig. 6c2) with
respect to group D (Fig. 6c3). Quantitatively, synapsin-IR
significantly decreased in nerve terminals in-group A and
B, but not in-group C (p ≤ 0.05) (Table 2).
Ferritin-H immunoreactivity (FH-IR)
FH-IR was increased in PCs of group B (Fig. 7b1), with less
significant changes in groups A and C (Fig. 7a and 7c,
respectively), when compared with FH-IR in group D (Fig.
7b3). Quantitatively FH-IR was significantly increased in
group B with respect to group D (p ≤ 0.05) (Table 2). No
significant changes in FH-IR was seen in group A and C,
however, there seems to be a redistribution of immunore-
activity (punctated) pattern in cells of the granular layer in
group A, as compared with group D.
Discussion
In this study we found that chronic mild CO exposure (25
ppm) promotes an increase in SOD-1, SOD-2, HO-1,
iNOS and NT in the cerebellum. These changes correlated
with a decrease in neurofilament proteins, synapsin-1 and
GAD immunoreactivity. The cerebellar cortex from group
B (pre and postnatal CO-exposure) showed a similar pat-
tern of immunoreactivity as for group A (prenatal CO
Table 2: Immunocytochemical quantification in the cerebellar 
cortex of groups A, B, C and D.
Marker Group A Group B Group C Group D
SOD1 43.8 ± 1.2
(+24)*
73.6 ± 6
(+108)*
62.8 ± 1.5
(+78)*
35.3 ± 1.2
SOD2 62.8 ± 5.8
(+83)*
78.6 ± 6.7
(+129)*
36 ± 1.8
(+5)
34.2 ± 2.7
HO1 49.5 ± 2.6
(+115)*
54.2 ± 1.7
(+135)*
37 ± 1.4
(+61)*
23 ± 1.9
iNOS 53.2 ± 4.1
(+93)*
65.4 ± 5.3
(+138)*
59 ± 3.7
(+114)*
27.5 ± 2.5
nNOS 51.8 ± 6
(-13)
36.3 ± 4
(-61)*
52.3 ± 6
(-12)
59.2 ± 8
eNOS 79.5 ± 7
(+6)
80.3 ± 6
(+7)
73 ± 6
(-3)
75.3 ± 5
Nitrotyrosine 25.7 ± 4.3
(+109)*
31.8 ± 2.6
(+159)*
26.4 ± 3.9
(+115)*
12.3 ± 2.2
Neurofilaments 39.5 ± 4
(-61.71)*
35.6 ± 5.2
(-56)*
40 ± 6.2
(-62)*
64 ± 4
GFAP 64.6 ± 1.4
(+131)*
45.8 ± 1.4
(-7)
47.2 ± 1.9
(-4)
49.2 ± 2.2
Parvalbumin 44.5 ± 9.8
(-1.7)
37.8 ± 7.5
(-17)
44 ± 8.5
(-2.9)
45.3 ± 9.5
GAD 63 ± 5.2
(-20)*
60 ± 5.8
(-24)*
57.6 ± 4.6
(-27)*
79 ± 7.8
Calbindin 44 ± 12
(-10)
48 ± 12.5
(-2)
46.7 ± 12
(-5)
49 ± 13
Synapsin 31 ± 4
(-39)*
17.6 ± 3
(-65.5)*
42 ± 6.5
(-18)
51 ± 4.4
Ferritin-H 80 ± 5.6
(+1.3)
113 ± 5
(43)*
79.5 ± 1.9
(+0.6)
79 ± 3.6
± = standard error of the mean.
() = % from the control. + = increased immunoreactivity, - = 
decreased immunoreactivity.
Comparisons were made by one way ANOVA. Group D vs. group A, 
group D vs. group B and group D vs. group C. *Values were 
considered statistically significant when p values were ≤ 0.05.
nns: non significant.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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exposure). Immunocytochemical changes were less prom-
inent in group C (postnatal exposure). Changes with these
markers and treatments were studied only at P20, when
the development of the cerebellum is yet active. These
results suggest that deleterious and protective mecha-
nisms were activated upon mild chronic CO exposure
over the period of dynamic development of the cerebellar
cortex.
Prenatal CO exposure in our rat model simulates the con-
ditions of CO exposure of a human fetus whose mother is
a mild to modest cigarette smoker, with clinical implica-
tions, in terms of persistent/permanent damage to fetuses
caused by CO in cigarette smoke or from the ambient air
that contains CO. Tobacco smoking during pregnancy has
been implicated as an etiologic factor of low birth weight
and pre-maturity, in utero; cigarette smoke exposure
restricts blood flow in the uterine and umbilical-placental
circulation either acutely through nicotine and/or other
vasoactive agents released in response to smoking, or
chronically by structural alterations to the placenta [50].
In our most recent publication on the rat peripheral audi-
tory system [42], we showed that prenatal chronic mild
CO exposure at the same concentration used in the
present study increases SOD-1, HO-1, iNOS and NT
immunoreactivity parallel to deterioration of afferent ter-
minals that innervate the inner hair cells within the devel-
oping cochlea [42].
Oxidative stress and damage
Oxidative stress in a physiological setting can be defined
as an excessive bioavailability of reactive oxygen species
(ROS), which is the net result of an imbalance between
production and destruction of ROS (with the latter being
influenced by antioxidant defences) [51]. The contempo-
rary definition of oxidative stress has been refined to
account for two different mechanistic outcomes, macro-
molecular (oxidative) damage, and disruption of thiol
iNOS, nNOS and eNOS – IR in the cerebellar cortex of CO-exposed rats Figure 2
iNOS, nNOS and eNOS – IR in the cerebellar cortex of CO-exposed rats. Fig. (a), (a1), and (a2), shows elevated 
iNOS-IR (see arrows), in neurons of the 3 layers in group A, B and C. (a3), group D shows almost no iNOS IR. Fig. (b, b1, b2, 
and b3) shows nNOS-IR mainly in neuronal bodies in the P layer (see arrows). Group B shows decreased nNOS-IR in PCs, 
group A and C shows close to normal nNOS IR. (b3) group D shows normal nNOS-IR. Fig. (c), (c1), and (c2), shows eNOS-IR 
in blood vessels in groups A, B, and C, respectively. eNOS IR in the 3 CO-groups was similar and close to normal. (c3) group 
D shows normal eNOS IR. Hematoxylin (in purple color) identifies cell nuclei. Bar in Fig. a-a3, and b-b3 is 150 um. Fig. c-c3 bar 
is 35 um.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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redox circuits, which leads to aberrant cell signaling and
dysfunctional redox control [51,52]. Macromolecular
damage is considered in terms of oxidative mechanisms
linked to free radicals, which are small, diffusible mole-
cules that differ from most biological molecules in that
they have an unpaired electron (i.e. superoxide anion rad-
ical, CO, NO, hydroxyl radical). The free radicals NO and
superoxide react to generate the non-radical oxidant per-
oxynitrite. Thiol-containing proteins that function in
redox signaling and physiological regulation are suscepti-
ble to two-electron oxidation by non-radical oxidants,
including hydrogen peroxide, lipid peroxides, aldehydes,
quinines and disulfides [53]. Either abnormal oxidation
or irreversible modification can interfere with reversible
oxidation-reduction reactions of thiols that physiologi-
cally function in receptor signaling, transcriptional regula-
tion, cell proliferation, angiogenesis and apoptosis. Thus
the contemporary refinement in the definition of oxida-
tive stress represents a shift to include both non-radical
oxidants and reversible oxidative reactions of redox sign-
aling and controls as key components of oxidative stress.
CO in cellular redox signalling
As reviewed by Piantadosi et al., and references therein
[54], cellular effects of CO are produced primarily by CO
binding to iron or other transition metals, which may also
promote pro-oxidant activities of the more reactive gases,
oxygen and NO. The effects of CO on the mitochondrial
oxidation-reduction (redox) state are well recognized
because CO binds the reduced iron (Fe2+) in the a3 heme
of the terminal electron acceptor of the respiratory chain,
cytochrome c oxidase. CO increases mitochondrial ROS
production in vitro and in vivo, and mitochondria metab-
olize CO by oxygenation to CO2. CO also binds to
reduced transition metals and other metalloenzymes
including guanylate cyclase (GC) and cytochrome P450,
therefore, CO-heme ligand formation tends to interfere
with redox reactions involving molecular oxygen as well
as NO. The activation of the GC system by CO and NO
occurs by binding the active heme and enhancing cGMP
production [54]. NO is more potent than CO in activating
GC in vasodilation, CO regulates vascular smooth muscle
in hypoxia. NO unlike CO, binds to both Fe2+ and Fe3+
heme, and low CO concentrations stimulate NO release
and are associated with peroxynitrite generation in vascu-
lar cells [2,5]. It has been proposed by Calabrese et al.,
[55] that HO-1 and/or CO and iNOS and/or NO are func-
tionally interrelated in mediating their protective effects.
In some situations, CO can activate the expression of
iNOS, in others, inhibits the expression of iNOS. NO up-
regulates HO-1 with the production of CO [55].
SOD-1 and SOD2
SOD-1 immunoreactivity was high in PCs of the cerebel-
lar cortex in groups A, B, and C suggesting that SOD-1 and
SOD-2 may serve as a defense system against ROS induced
injury. SOD-1 has a widespread distribution in a variety of
cells [56]. SOD-1 is constitutively expressed, and its
mRNA levels can be dramatically upregulated by a wide
array of mechanical, chemical and biological messengers.
SOD-2 is a highly inducible mitochondrial protein capa-
ble of protecting the brain from oxidative damage; its
expression has been demonstrated to be critical in modu-
lating the response of neurons to different type of stress
Quantitative real time RT-PCR expression of iNOS, nNOS and eNOS in the cerebellar cortex of CO-exposed rats Figure 3
Quantitative real time RT-PCR expression of iNOS, nNOS and eNOS in the cerebellar cortex of CO-exposed 
rats. Fig. (a) iNOS mRNA was significantly up-regulated (asterisk) in group B, followed by groups A and C, group D shows the 
normal expression. (b) nNOS and (c) eNOS mRNA in groups A, B and C, showed no significant changes with respect to con-
trol group-D. Results represent standard error of the mean from 3 experiments for each group.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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[56,57]. SOD-2 is synthesized within the cytosol and
imported to the mitochondrial matrix, where it converts
superoxide anion to hydrogen peroxide. Within the mito-
chondria, the hydrogen peroxide is then converted either
to water by mitochondrial glutathione peroxidase or cata-
lase, or can participate in Fenton type chemistry, giving
rise to further ROS such as the hydroxyl radical [58]. Thus,
SOD-2 can acts as a fundamental defense against ROS
within the mitochondria [59]. Increased levels of SOD-2
protein, mRNA, and enzymatic activity have been amply
documented in the rodent brain as a consequence of nor-
mal aging, ischemia, hyperoxia, and pro-oxidant drug
exposure [58-60]. We detected a significant increase in
SOD-2-IR in cerebellar neurons in groups A and B, and a
less significant change in group C. These results suggest
that a protective mechanism mediated by SOD-2 is acti-
vated after CO exposure.
HO-1 and HO-2
HO-1 but not HO-2 was up regulated in neurons of the
cerebellar cortex of CO exposed pups in groups A and B,
and in contrast, there was a mild upregulation of HO-1 in
group C. The heme oxygenase isozymes, HO-1 and HO-2,
oxidatively cleave the heme molecule to produce biliver-
din and CO [61-66]. The cleavage results in the release of
iron, a regulator of transferrin, ferritin and NOS gene
expression [61,65]. HO-1 is a heat shock protein (HSP-
32) induced under numerous conditions of cellular stress
[63-66]. HO-1 upregulation suggests that a protective
mechanism is activated in response to adverse cellular oxi-
dative conditions. HO-2-IR did not change in the three
CO exposed groups with respect to the control (not
shown). HO-2 is responsible for most of the HO constitu-
tive activity [64].
Nitric oxide synthases and NT in the cerebellar vasculature 
after CO exposure
There was a significant upregulation of iNOS in the soma
of the PCs and endothelial cells of the blood vessels
within the cerebellum in all CO-exposed groups. The
upregulation of the iNOS is accompanied by an increase
in the expression of iNOS mRNA. Evidence that the upreg-
ulation of iNOS produces a detrimental amount of its
product, NO, in the cerebellum was shown by the pres-
ence of NT in endothelial cells of the blood vessels and to
a lesser extent the soma of the PCs. NT is a relatively spe-
cific stable biochemical marker for peroxynitrite forma-
tion [67] particularly when significant amounts are
present [68-70]. Inducible-NOS is also controlled by
inflammatory mediators and cytokines and iNOS up-reg-
ulation, produces large quantities of NO, whereas nNOS
and eNOS produce low amounts of NO [71]. Exogenous
and endogenous CO exerts its action by modifying the
NO system, including modulation of soluble guanylate
cyclase [72-75]. Our results suggest that chronic exposure
at mild CO concentrations (12–25 ppm) perturb both the
CO and NO systems in the cerebella. The persistence of
markers indicating oxidative stress in group A by P20, fol-
lowing prenatal only CO-exposure demonstrates the con-
dition is sustained.
By contrast, nNOS-IR was substantially reduced in the cer-
ebellum of CO-exposed animals from group B, with no
significant change in groups A and C. A decrease in nNOS-
IR without a detectable change in the abundance of the
mRNA, suggests that oxidative stress may affect the func-
tion of this enzyme [76]. Interestingly eNOS in the three
CO-exposed groups remains relatively unchanged with
respect to the control. It is possible that with time (i.e.
more than 20 days) after CO exposure a change in eNOS
expression may become evident.
We only detected NT as an index of protein nitrosylation,
additional methods such as protein oxidation [77] could
supplement our findings. Also it is important to mention
that the detection of lipid peroxidation and DNA oxida-
tion have yet to be pursued in our laboratory to provide
the definitive account on whether the upregulation of the
several enzymes examined prevent oxidative damage or
not. There is also a need to determine whether these
changes are permanent or transient by studying their
expression in adult animals following our prenatal/post-
natal CO-exposure conditions.
NT-IR in the cerebellar cortex of CO-exposed rats Figure 4
NT-IR in the cerebellar cortex of CO-exposed rats. 
Fig. (a) group A, (b) group B, and (c) group C, shows NT-IR 
in blood vessels (single arrows) of the 3 layers. PC cytoplasm 
showed NT-IR (double arrows). Fig. (d) group D, NT-IR was 
absent in blood vessels or neurons. Hematoxylin (in blue-
purple color) identifies cell nuclei. Bar in all Figs. is 75 um.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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Prenatal CO exposure and hypoxia
When inhaled, CO is readily absorbed from the lungs into
the blood-stream, where it forms a tight but slowly revers-
ible complex with hemoglobin (Hb) known as carboxyhe-
moglobin (COHb). The presence of COHb in the blood
decreases the oxygen carrying capacity, reducing the avail-
ability of oxygen to body tissues and resulting in tissue
hypoxia [1,8]. At 10 ppm the estimated COHb in blood is
2%, and at 70 ppm it is 10% [1]. Using similar CO expo-
sure conditions at 100 ppm on rat pups over the postnatal
weeks we have reported COHb in amounts up to 10%, but
there was some overlap with controls [39]. We did
attempt to measure COHb in the animals exposed at 25
ppm, and at this concentration there was no obvious dif-
ference where values were in the range 2 to 5% for test and
controls.
Carbon monoxide from tobacco smoke easily crosses the
placental barrier by passive diffusion, causing a 4-fold
increased level of COHb in umbilical cord blood; this has
the property of inhibiting the release of oxygen into fetal
tissues across the placenta in prenatal exposure [78]. The
consequent chronic hypoxia may alter the physiological
development of organs susceptible to hypoxic damage
including the brain. Our data shows that prenatal CO
exposure increases several proteins related to oxidative
stress and neuronal function in a similar fashion that was
found for prenatal plus postnatal exposure. Lavezzi et al.,
[78] showed a decreased noradrenergic activity in the
locus coeruleus and EN2 gene expression in the arcuata
nucleus and somatostatin in the hypoglossal nucleus in
the brainstem by comparing still births of mothers who
were smokers versus those from mothers who were non-
smokers. In a related study Matturri et al., [79] found a sig-
nificant relationship between maternal smoking and
brainstem alterations (hypodevelopment of the arcuate
nucleus, gliosis, hypoplasia of the hypoglossus nucleus).
The hypoxic effect by CO could be discerned by subjecting
the animals to hypoxic only conditions [80] i.e. low oxy-
gen concentrations (hypoxygenation), and then compar-
ing the similar oxidative stress markers. Gene expression
analyses could provide additional information. Gess et
al., [80] subjected rats to hypoxia (low oxygen tension) or
0.1% CO (1000 ppm) from 0.5 to 6 hrs. They detected
increased c-fos mRNA levels in the heart after 0.5 hr, and
at 0.1% of CO after 6 hours of exposure the increase in
mRNA was even more significant. There was an organ
selective increase of c-fos, however they did not measure
the levels of c-fos mRNA in the brain. We have begun to
address this issue in our CO exposure model (25 ppm
exposure) by screening for the expression of 86 hypoxia-
associated genes in the rat cerebella using real time RT-
PCR. We found up-regulation of erythropoietin and
down-regulation of leptin mRNA with no significant
changes on HIF factor 1 and 3 [49].
Neurofilaments and synapsin after CO exposure
At P20, neurofilament and synapsin-1-IR are low in the
three CO-exposed groups as compared to controls. A
decrease in neurofilament proteins and synapsin-1, a
marker for efferent terminals, and well described for the
cerebellum [81,82] suggests that PCs and their terminals
are very sensitive to chronic mild CO exposure. Our ear-
NF-IR and GFAP-IR in the cerebellar cortex of CO-exposed rats Figure 5
NF-IR and GFAP-IR in the cerebellar cortex of CO-exposed rats. Fig. (a) group A, (a1) group B, and (a2) group C, 
showed decreased NF-IR in neurons of the 3 layers (arrows). (a3) group D shows normal NF-IR. (b) Group A, shows higher 
GFAP-IR in glial cells in M, P, and G layers (see arrows) than group D (b3). (b1) and (b2) group B and C in contrast, showed 
close to normal GFAP-IR. (b3) group D shows basal GFAP-IR. Hematoxylin (in purple color) identifies cell nuclei. Bar in all Figs. 
is 150 um.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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PV, GAD, CB and Syn-1-IR in the cerebellar cortex of CO exposed and control rat pups Figure 6
PV, GAD, CB and Syn-1-IR in the cerebellar cortex of CO exposed and control rat pups. Fig. (a), (a1), (a2) and 
(a3), PV IR in groups A, B, C, and D respectively shows PV-IR (in green color) in neuronal bodies and processes in the M, P, 
and G layers. PV-IR in all 3 CO-groups was not different when compared to group D. Fig. (b), (b1), (b2) and (b3), GAD-IR in 
groups A, B, C, and D respectively shows GAD-IR (green color) in neuronal bodies, processes and button terminals in the M, 
P, and G layers. GAD-IR in all 3 CO-groups was decreased when compared to the control, group D. Fig. (c), (c1), (c2) and (c3), 
shows CB-IR in groups A, B, C, and D respectively. CB-IR (green color) is localized mainly in PCs and their processes. Fig. (d), 
(d1), (d2) and (d3), shows Syn-1-IR (red dots) in groups A, B, C, and D. Syn-1-IR is localized in button terminals respectively of 
the 3 layers. There was a pronounced decrease in Syn-1-IR in group A and B and to a lesser extent (but not significant) in 
group C. Scale bar is 150 um in Figs. a-a3, and b-b3, and 200 um in figs c-c3 and d-d3.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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lier studies on postnatal CO-exposure showed that
chronic mild CO exposure permanently decreases basal c-
fos in another region of the brain, the central nucleus of
the inferior colliculus [40,41], a condition that can be pre-
vented by the dietary reduction of iron without anaemia
[41]. In this study we concluded the Fenton reaction was
diminished sufficient to avoid the consequences of
chronic mild CO exposure [41].
Parvalbumin and Calbindin after CO exposure
We found that PV and CB immunoreactivity remain unal-
tered in the three CO-exposed groups. PV and CB are two
calcium-binding proteins expressed abundantly in the cer-
ebellar cortex [35,83-86]. The cerebellum is a highly
organized structure in which PCs are the sole output of the
cerebellar cortex. These cells are aligned in a single plane,
parallel to the surface of the cortex and they can be specif-
ically stained with antibodies directed against PV or CB
[35,85]. In most species, all PCs (soma and dendrites)
show CB-IR from an early stage of embryonic develop-
ment [84,86]. It is suggested that calcium-binding pro-
teins play a role in the regulation of intracellular calcium
signaling cascades, therefore, important to the cell firing,
and they are also related to changes in sensory inputs
[83,86]. The fact that we found no changes in PV-IR or CB-
IR does not rule out changes in these two proteins in the
long term, or changes in other calcium binding proteins/
molecules, such as calretinin or IP3.
Glutamic acid decarboxylase
We found that CO exposure results in a significant
decrease in GAD in all three CO exposed groups. GAD is
the enzyme responsible for the synthesis of GABA, an
important inhibitory neurotransmitter of the cerebellum,
which contains a high number of GABA synthesizing neu-
rons [87]. Our results are in line with previous studies that
showed significant decreases in total cerebellar GABA con-
tent following pre- and postnatal exposure to 150 or 300
ppm of CO [29]. More recently two studies by Benagiano
et al., [22,23] also demonstrate that prenatal CO exposure
(75 ppm) affects (decreases) quantitatively GAD and
GABA immunoreactivity in the rat cerebellar cortex. These
studies were made in the cerebellar cortex of the Vermis.
For these experiment [22,23], pregnant rats were exposed
to 75 ppm CO in air from day 0–5 to day 20 of pregnancy.
The resulting progeny were killed at 120–150 days postna-
tal. The 75 ppm CO-exposure condition used by Benagi-
ano [22,23] induces a relatively mild decrease of oxygen
availability to fetuses, but does not impair CNS develop-
ment [88]. The decrease of GAD immunoreactivity in our
study after prenatal, pre- and postnatal and postnatal CO
exposure at 25 ppm, support the idea that lower concen-
trations of CO are still detrimental to cerebellar develop-
ment and in turn would create physiological deficits.
GFAP
In group A (prenatal only CO exposure), there is an up-
regulation of GFAP-IR in astroglia in the granular layer
and in the Bergman glial (BG) cells located in the PC and
molecular layer [89,90]. In contrast, group B (pre and
postnatal CO exposure) and group C (postnatal CO expo-
sure only) show no alteration in GFAP-IR, being indistin-
guishable from data for the cerebella of group D. These
results suggest that it is important to prevent CO exposure
(even at very mild CO exposure) in the prenatal period.
Either down-regulation or up-regulation of GFAP may
have detrimental consequences to the proper develop-
ment of the CNS [91]. Up-regulation of GFAP-IR indi-
cated glial activation [92]. Indeed glial activation has been
detected in the rat brain after acute CO exposure [92], and
it has been suggested that activated microglia can mediate
cognitive dysfunction by impairing neurogenesis and by
causing necrosis or apoptosis [93,94].
Ferritin
The iron-storage protein ferritin is a 24-subunit protein
involved in the regulation of iron availability [95,96].
Mammalian ferritin contains variable amounts of two
types of polypeptide chain, heavy (H) and light (L). H-
chain ferritins are associated with responses to stress,
whereas L-rich ferritins are associated with iron storage
[97]. The subunit composition of ferritin proteins (H:L
ratio) is cell- and tissue-specific. In the CNS, microglia
contain mostly L-rich ferritin, neurons contain mostly H-
rich ferritin, and oligodendrocytes contain equal amounts
of both isoforms [98]. In the present study ferritin H was
significantly increased in cells of the cerebellar cortex in
FH-IR in the cerebellar cortex of CO-exposed rats Figure 7
FH-IR in the cerebellar cortex of CO-exposed rats. 
Fig. (a) group A, (b) group B, (c) group C and (d) group D, 
shows FH-IR appearing as an amber colored precipitate, (see 
arrows) in neuronal bodies and neuropile in the M, P, and G 
layers. Hematoxylin (in purple color) identifies cell nuclei. 
Bar in all Figs. is 150 um.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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group B (pre and postnatal exposure); there was a redistri-
bution of FH-IR in cells of the granular layer in group A.
Group C showed a similar immunoreactive patterns to the
control group D. No changes in ferritin-L immunoreactiv-
ity were detected in cerebellar cells of the three CO
exposed groups with respect to the air controls (not
shown). Ferritin-H upregulation (increased immunoreac-
tivity) may occur as a compensatory mechanism to coun-
teract increased amounts of iron that is caused by the
release of iron from heme proteins [95]. In this respect we
did not detect free iron (using Prussian blue staining) in
the rat cerebellar cortex of the three CO groups (data not
shown).
Relevance of mild chronic CO exposure during prenatal 
development
Our results show that the detrimental effect of chronic
mild prenatal exposure to CO (at the levels expected from
mild active smoking, second hand smoke in poorly venti-
lated home environments) can occur within the cerebella.
This is important given that CO is not the only compo-
nent in cigarette smoke, or the only source of this gas in
the atmosphere [1]. The fact that markers for regulatory
signal systems involving SOD-1, SOD-2, HO-1, iNOS, NT
and ferritin are increased supports the idea that neuronal
competencies are affected because of a persistent state of
oxidative stress after chronic mild exposure to CO.
We propose that CO is not a toxin at low concentrations
(0.0025% in air). Rather, a chronic environment of exog-
enously available CO can act as an aberrant neuromodu-
lator in-vivo, subverting the signal activities of naturally
produced CO and NO and related processes. This finding
indicates that neuronal cell functions that depend on
nNOS involvement are compromised in cells when there
is prolonged NO production from at least the persistent
over expression of iNOS. As a consequence, regulatory sig-
nal systems involving inducible HO-1 and iNOS are per-
sistently not optimal.
Molecular and cellular effects of CO exposure, oxidative
stress and redox signalling are well documented in several
in-vivo and in-vitro models [2,3,5,54,55,99]. The changes
we observed by immunocytochemistry and mRNA analy-
ses on oxidative stress markers and on structural and func-
tional proteins after prenatal chronic very mild CO
exposure serve as the basis to examine mechanistic rela-
tionships among cell signalling pathways, antioxidant
defense processes and putative pathological endpoints for
the developing cerebellum.
The study of the effects of the chronic presence of very
mild CO concentrations in air during prenatal develop-
ment is relevant for several reasons: (a) Vulnerability. CO
readily crosses the placenta, favoring a mild increase in
oxidative stress that "normally" occurs in early develop-
ment. Ferriero [100] indicates that the increased suscepti-
bility to oxidative injury can be explained by several
mechanisms that facilitate the production of reactive oxy-
gen species from the increased presence of hydrogen per-
oxide that tends to accumulate because of immature
defense mechanisms. It is indicated the inadequate scav-
enging abilities inherent to developing systems are not
sufficient to maintain glutathione stores in neonatal neu-
ral tissue that also contains more available iron than is
present in mature neural tissue. (b)CO exposure conditions
and the developing cerebella. The rat cerebellar PCs are gen-
erated prenatal, whereas stellate or basket cells are pro-
duced postnatal [101]. Thus the 3 CO exposure regimens
showed a differential expression of the cellular markers
examined in the present study. The combination of these
circumstances in normal development can result in a mild
state of oxidative stress [100]. (c)Relevance of mild CO con-
centrations. The chronic mild CO exposures used in our
studies, (intermittent and averaging about 12 hours in
each 24 hour period) are not toxic (poisonous) but at
amounts below the upper limits identified by most regu-
latory agencies as previously indicated [41]. The exposures
are the same or less than that reported for the home envi-
ronment especially where gas appliances are used, and
below the concentrations indicated to prevail in active
tobacco smokers who are pregnant or breast feed their off-
spring. For example, no standards for CO exposure have
been agreed upon for indoor air and the EPA indicates
that average CO levels in homes without gas stoves vary
from 0.5 to 5 ppm, (5 ppm is 0.0005% CO in air). Levels
near properly adjusted gas stoves are often 5 to 15 ppm
and those near poorly adjusted stoves may be 30 ppm or
higher. It is also indicated that today there is an emphasis
on insulating homes to save energy, conditions that can
contribute to poor ventilation http://www.epa.gov/iaq/
co.html. (d) Significance to existing human conditions.
Today oxidative stress is recognized as a condition com-
mon to many health problems [99,102,103]. It is consid-
ered to be a factor in the ageing process and known to be
involved in the initiation of cardiovascular disease. Oxi-
dative stress has been shown to be a component of many
neurodegenerative diseases such as Alzheimer's, Parkin-
son's, Huntington's, amyotrophic lateral sclerosis and
multiple sclerosis, as examples. A search of the scientific
literature on oxidative stress and for example, asthma,
cancer, and autism reveals that conditions of oxidative
stress can prevail. In our animal model we have shown
CO exposure can create and promote conditions of oxida-
tive stress. In the human situation where oxidative stress
is already present it can be predicted that chronically sup-
plied CO from the air or from the active smoking of
tobacco can be expected to exacerbate any of these health
conditions leading to a more pronounced condition of
oxidative stress.BMC Neuroscience 2009, 10:53 http://www.biomedcentral.com/1471-2202/10/53
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Conclusion
Six distinctive markers (HO-1, SOD-1, SOD2, ferritin,
iNOS and NT), known to be increased when there is oxi-
dative stress were significantly increased by exposure to
chronic mild CO concentrations over the fetal period and
the early postnatal period. Further, the up-regulation of
the gene for iNOS in relation to the generation of ROS cor-
roborated the immunocytochemical observations. The
persistence of markers indicating oxidative stress at 20
days postnatal following prenatal only CO-exposure dem-
onstrates the condition is chronic. The outcome from a
persistent oxidative stress may be selective. Synapsin-1,
neurofilament proteins and GAD, were significantly
decreased suggesting a suboptimal expression that would
not meet their respective cellular functions. The detrimen-
tal effect of chronic mild CO exposure on the cerebellar
cortex may be reflected in balance deficits given that an
adequate neural innervation is essential for the normal
development of neurons in the cerebella.
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